Kaufman Bros. Initiates Coverage on MEDNAX (MD) with a Buy; Material Upside Potential from Strong Acquisition Pipelines
Tweet Send to a Friend
Kaufman Bros. initiates coverage on MEDNAX, Inc. (NYSE: MD) with a Buy. Price target $69.
Kaufaman analyst says, "We view ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Kaufaman analyst says, "We view ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
